Mastitis is recognized as one of the most costly diseases affecting
dairy cows and a major cause of economic losses in the dairy industry
worldwide. In South Africa, milk with more than 500000 somatic cells/mL
is not approved for human consumption and therefore it cannot be sold.
The effect of just a few cows with very high SCC on the bulk milk (tank)
is so large that the entire milk from a tank can be penalised, although
the vast majority of the cows have low cell counts. The SCC can be
effectively controlled with antibiotic therapy, but this practice is
currently not acceptable. There is a need to develop alternative
strategies, besides good management practices to improve udder health
and milk quality and to control SCC. The potential use of natural
immunostimulant substances for human and animal health is gaining
interest. There are some claims that a lysate of corynobacterium cutis -
a non-specific immunostimulant, boosts the immune system of animals,
rendering them more resistant to diseases in general. The main aim of
this study was to evaluate the effectiveness of inoculations of
Corynebacterium cutis lysate, to reduce the milk SCC's in commercial
dairy cows.